HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesSepiapterin
Chemical structure of CAS 17094-01-8

Sepiapterin

In Stock•Starting at $803 for 1 mg•Purity ≥ 98.9795%
CAS No.17094-01-8
MDL No.MFCD00210214
MFC9H11N5O3
MW237.22
InChI KeyVPVOXUSPXFPWBN-VKHMYHEASA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98.9795%$803In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

L-sepiapterin is a sepiapterin with L configuration.

CAS No.17094-01-8
Product NameSepiapterin
Heavy Atom Count17Rotatable Bond Count2
Atom Stereo Count1Bond Stereo Count0
HBA7HBD4
TPSA133.460 ŲCharge0
Exact Mass237.08619Complexity560.24
pKa7.130XLogP-1.200

Related Articles

Studies related to this compound and its mechanism of action

Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.

The FEBS journal • Vol. 281, Issue 16 • 2014
PMID: 24964743DOI: 10.1111/febs.12893

4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation.

Arteriosclerosis, thrombosis, and vascular biology • Vol. 27, Issue 11 • 2007
PMID: 17872449DOI: 10.1161/ATVBAHA.107.153742

Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction.

Arteriosclerosis, thrombosis, and vascular biology • Vol. 25, Issue 8 • 2005
PMID: 15933248DOI: 10.1161/01.ATV.0000172626.00296.ba

GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in rats.

American journal of physiology. Heart and circulatory physiology • Vol. 285, Issue 5 • 2003
PMID: 12855421DOI: 10.1152/ajpheart.00253.2003

Documentation